Time Since Last Anti-CD20 Treatment Is a Major Determinant of Sars-Cov-2 Vaccine Response in a Large Cohort of Patients with B-Cell Lymphoma

被引：0
|
作者：
Shree, Tanaya [1 ]
Shankar, Vishnu [1 ]
Czerwinski, Debra K. [2 ]
Rodriguez, Gladys [1 ]
Beygi, Sara [3 ,4 ]
Schroers-Martin, Joseph G. [5 ,6 ]
Advani, Ranjana [7 ]
Maeda, Lauren S. [2 ,8 ]
Gupta, Neel K. [2 ,8 ]
Khodadoust, Michael S. [1 ,9 ]
Kurtz, David M. [1 ]
Corbelli, Karen S. [10 ]
Gabriel, Etelka [1 ]
Kanegai, Alyssa M. [1 ]
Alizadeh, Ash A. [11 ,12 ]
Levy, Ronald [1 ]
机构：
[1] Stanford Univ, Dept Med, Div Oncol, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Med Ctr, Div Oncol, Dept Med, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Div Oncol, Stanford, CA 94305 USA
[5] Stanford Univ, Div Hematol, Dept Med, Stanford, CA USA
[6] Stanford Univ, Div Oncol, Dept Med, Stanford, CA USA
[7] Stanford Canc Inst, Lymphoma, Dept Med, Div Oncol, Stanford, CA USA
[8] Stanford Univ, Med Ctr, Div Hematol, Dept Med, Stanford, CA 94305 USA
[9] Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA
[10] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[11] Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA
[12] Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-153901
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2064
引用
收藏
页数：6
相关论文
共 50 条
  • [41] Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab
    Assayag, Franck
    Brousse, Nicole
    Couturier, Jerome
    Macintyre, Elizabeth
    Mathiot, Claire
    Dewulf, Sebastien
    Froget, Benoit
    Vincent-Salomon, Anne
    Decaudin, Didier
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (06) : 387 - 388
  • [42] SARS-CoV-2 Infection and Antibody Response in a Symptomatic Cat from Italy with Intestinal B-Cell Lymphoma
    Klaus, Julia
    Palizzotto, Carlo
    Zini, Eric
    Meli, Marina L.
    Leo, Chiara
    Egberink, Herman
    Zhao, Shan
    Hofmann-Lehmann, Regina
    VIRUSES-BASEL, 2021, 13 (03):
  • [43] Evaluation of CYCLON as a predictive biomarker of anti CD20 response in diffuse large B-Cell lymphoma
    Bouroumeau, A.
    Bussot, L.
    Bonnefoix, T.
    Callanan, M.
    Gressin, R.
    Emadali, A.
    Sartelet, H.
    VIRCHOWS ARCHIV, 2019, 475 : S338 - S338
  • [44] Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy
    Gadani, Sachin P.
    Reyes-Mantilla, Maria
    Jank, Larissa
    Harris, Samantha
    Douglas, Morgan
    Smith, Matthew D.
    Calabresi, Peter A.
    Mowry, Ellen M.
    Fitzgerald, Kathryn C.
    Bhargava, Pavan
    EBIOMEDICINE, 2021, 73
  • [45] It is time to adapt anti-CD20 administration schedules to allow efficient anti-SARS-CoV-2 vaccination in patients with lymphoid malignancies
    Besson, Caroline
    HAEMATOLOGICA, 2022, 107 (03) : 572 - 573
  • [46] Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
    Apostolidis, Sokratis A.
    Kakara, Mihir
    Painter, Mark M.
    Goel, Rishi R.
    Mathew, Divij
    Lenzi, Kerry
    Rezk, Ayman
    Patterson, Kristina R.
    Espinoza, Diego A.
    Kadri, Jessy C.
    Markowitz, Daniel M.
    Markowitz, Clyde E.
    Mexhitaj, Ina
    Jacobs, Dina
    Babb, Allison
    Betts, Michael R.
    Prak, Eline T. Luning
    Weiskopf, Daniela
    Grifoni, Alba
    Lundgreen, Kendall A.
    Gouma, Sigrid
    Sette, Alessandro
    Bates, Paul
    Hensley, Scott E.
    Greenplate, Allison R.
    Wherry, E. John
    Li, Rui
    Bar-Or, Amit
    NATURE MEDICINE, 2021, 27 (11) : 1990 - +
  • [47] Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
    Sokratis A. Apostolidis
    Mihir Kakara
    Mark M. Painter
    Rishi R. Goel
    Divij Mathew
    Kerry Lenzi
    Ayman Rezk
    Kristina R. Patterson
    Diego A. Espinoza
    Jessy C. Kadri
    Daniel M. Markowitz
    Clyde E. Markowitz
    Ina Mexhitaj
    Dina Jacobs
    Allison Babb
    Michael R. Betts
    Eline T. Luning Prak
    Daniela Weiskopf
    Alba Grifoni
    Kendall A. Lundgreen
    Sigrid Gouma
    Alessandro Sette
    Paul Bates
    Scott E. Hensley
    Allison R. Greenplate
    E. John Wherry
    Rui Li
    Amit Bar-Or
    Nature Medicine, 2021, 27 : 1990 - 2001
  • [48] Analysis of vaccine responses after anti-CD20 maintenance in B-cell lymphoma in the Balearic Islands. A single reference center experience
    Gutierrez, Antonio
    Alonso, Aser
    Garcia-Recio, Marta
    Perez, Sandra
    Garcia-Mano, Lucia
    Martinez-Serra, Jordi
    Ros, Teresa
    Garcia-Gasalla, Mercedes
    Ferrer, Joana
    Voegler, Oliver
    Alemany, Regina
    Salar, Antonio
    Sampol, Antonia
    Bento, Leyre
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [49] Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapy
    Rico, Audrey
    Ninove, Laetitia
    Maarouf, Adil
    Boutiere, Clemence
    Durozard, Pierre
    Demortiere, Sarah
    Villarroel, Paola Mariela Saba
    Amroun, Abdennour
    Fourie, Toscane
    de Lamballerie, Xavier
    Pelletier, Jean
    Audoin, Bertrand
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (04)
  • [50] Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy
    Woopen, Christina
    Dunsche, Marie
    Al Rahbani, Georges Katoul
    Dillenseger, Anja
    Atta, Yassin
    Haase, Rocco
    Raposo, Catarina
    Pedotti, Rosetta
    Ziemssen, Tjalf
    Akgun, Katja
    VACCINES, 2023, 11 (09)
12345